Searched for
IMMUNOCOMPROMISED PATIENTS
Delhi records warmest night in 12 yearsDelhi experienced the warmest night in 12 years on Wednesday with the minimum temperature settling at 35.2 degrees Celsius, over eight notc...- AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patientsAstraZeneca's COVID-19 prevention therapy, sipavibart, has shown a significant reduction in symptomatic COVID-19 cases among immunocompromi...
- Karnataka to acquire precautionary vaccine doses for senior citizens, comorbid patientsKarnataka will also have a daily testing target of 5000, making it the second highest testing state after Kerala, the committee added. Whil...
- Third COVID-19 vaccine dose advised for immunocompromised people, says BMJ studyThe researchers from National University of Singapore analysed the results of 82 observational studies comparing the effectiveness of COVID...
- RNA-based therapy can protect from many Covid variants: StudyResearchers at Yale School of Medicine in the US noted that the molecule could lead to new treatments for COVID-19 in immunocompromised pat...
- Remdesivir to be used in patients with moderate to severe COVID-19: Health ministryThe Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disea...
- Covid: NTAGI discusses administering 'additional' vaccine dose, inoculation of kidsAnswering a list of frequently asked questions (FAQs) about the Omicron variant of coronavirus, the Health Ministry has said that while the...
- NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised peopleA booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have ...
- Covid-19: Key decision on booster dose likely to be taken this monthExperts are of the view that in diseases like cancer, the body of patients undergoing chemotherapy may not be able to generate enough immun...
- UK to roll out life-saving COVID-19 treatment which was given to Donald TrumpThe treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.
- The Covid booster shot is not for everyone. It's only meant for severely immunocompromised peopleBooster shots are often identical to the original vaccine.
- Can Covid vaccines work on compromised immune systems?Immunocompromised people aren't a uniform group, and so may respond to vaccines differently.
- Should people with immune problems get third vaccine doses?Several studies have indicated that a third coronavirus vaccine dose might succeed in patients who did not have detectable antibodies after...
- States, UTs allocated additional 61,120 vials of Amphotericin-B: Sadananda Gowda7.9 lakh vials have been allocated across the country, maintaining adequate availability to patients of mucormycosis. Amphotericin-B is use...
- Govt allocates additional 1,21,000 vials of Amphotericin-B to states, UTs, central institutionsAmphotericin-B is used to treat mucormycosis, also known as black fungus infection.
- Govt allocates additional 23,680 vials of Amphotericin-B to states/UTs: Sadananda GowdaAs per the Union Health Ministry, Mucormycosis is being detected among patients who are recovering or have recovered from COVID-19.
- Mucormycosis cases rise: How this deadly black fungal infection is making people blindThe fungal infection is caused by a group of molds called mucormycetes. These molds live throughout the environment. Mucormycosis mainly af...
- Lack of clarity on Covid vaccines' safety may derail India's next phase of inoculationThis could mean a large section of the people with comorbidities such as diabetes, hypertension and heart disease — who are among the prior...
- Mildly ill COVID-19 patients might be discharged in nine or more days after symptom onset: StudyScientists have assessed respiratory samples from 35 COVID-19 patients, and found that contagious coronavirus was "rarely detectable" beyon...
- Alembic Pharma gets USFDA nod for Acyclovir ointmentThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Acyclovir ointment USP, 5 per cent, Alembi...
Load More
